Andon Health Co., Ltd. (SHE:002432)
China · Delayed Price · Currency is CNY 40.05
-0.45 (-1.11%)
Nov 3, 2025, 2:45 PM CST
Andon Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,556 | 2,578 | 3,172 | 26,265 | 2,340 | 1,996 | Upgrade |
Other Revenue | 13.85 | 13.85 | 58.66 | 50.51 | 57.06 | 11.9 | Upgrade |
| 1,569 | 2,592 | 3,231 | 26,315 | 2,397 | 2,008 | Upgrade | |
Revenue Growth (YoY) | -39.13% | -19.77% | -87.72% | 997.80% | 19.36% | 184.36% | Upgrade |
Cost of Revenue | 562.48 | 784.96 | 1,275 | 5,529 | 884.82 | 906.6 | Upgrade |
Gross Profit | 1,007 | 1,807 | 1,956 | 20,786 | 1,512 | 1,102 | Upgrade |
Selling, General & Admin | 922.08 | 863.38 | 886.05 | 2,004 | 496.55 | 592.82 | Upgrade |
Research & Development | 306.77 | 260.69 | 278.46 | 264.89 | 66.73 | 76.54 | Upgrade |
Other Operating Expenses | 4.5 | 3.4 | 41.6 | 4.15 | 6.25 | 7.34 | Upgrade |
Operating Expenses | 1,242 | 1,130 | 1,203 | 2,286 | 592.96 | 686.29 | Upgrade |
Operating Income | -235.38 | 677.15 | 752.66 | 18,500 | 919.31 | 415.47 | Upgrade |
Interest Expense | -106.91 | -67.16 | -12.43 | -4.75 | -13.3 | -6.95 | Upgrade |
Interest & Investment Income | 875.11 | 800.45 | 735.36 | 274.1 | 62.35 | 327.17 | Upgrade |
Currency Exchange Gain (Loss) | -11.92 | -11.92 | 40.13 | 35.26 | -2.2 | -18.8 | Upgrade |
Other Non Operating Income (Expenses) | 0.27 | -2.26 | -2.8 | -1.98 | -3.86 | -2.65 | Upgrade |
EBT Excluding Unusual Items | 521.16 | 1,396 | 1,513 | 18,803 | 962.29 | 714.23 | Upgrade |
Impairment of Goodwill | - | - | -89.5 | -125.26 | - | -123.43 | Upgrade |
Gain (Loss) on Sale of Investments | 1,394 | 735.6 | 309.29 | -326.4 | 30.49 | -336.92 | Upgrade |
Gain (Loss) on Sale of Assets | 0.94 | 0.67 | -0.5 | -6.43 | 0.01 | -0.03 | Upgrade |
Asset Writedown | -30.6 | -25.45 | -153.14 | -46.95 | -1.88 | -24.29 | Upgrade |
Other Unusual Items | 1.02 | -0.2 | 1.28 | -39.85 | 8.72 | 10.19 | Upgrade |
Pretax Income | 1,886 | 2,107 | 1,580 | 18,258 | 999.63 | 239.75 | Upgrade |
Income Tax Expense | 31.82 | 306.83 | 231.11 | 1,774 | 65.23 | 2.92 | Upgrade |
Earnings From Continuing Operations | 1,854 | 1,800 | 1,349 | 16,484 | 934.4 | 236.83 | Upgrade |
Minority Interest in Earnings | 34.93 | -131.31 | -97.62 | -453.93 | -25.76 | 5.5 | Upgrade |
Net Income | 1,889 | 1,669 | 1,252 | 16,030 | 908.64 | 242.33 | Upgrade |
Net Income to Common | 1,889 | 1,669 | 1,252 | 16,030 | 908.64 | 242.33 | Upgrade |
Net Income Growth | 9.61% | 33.33% | -92.19% | 1664.19% | 274.96% | 264.68% | Upgrade |
Shares Outstanding (Basic) | 441 | 438 | 445 | 456 | 455 | 433 | Upgrade |
Shares Outstanding (Diluted) | 442 | 441 | 452 | 467 | 455 | 433 | Upgrade |
Shares Change (YoY) | 5.76% | -2.49% | -3.23% | 2.82% | 5.02% | -2.30% | Upgrade |
EPS (Basic) | 4.28 | 3.81 | 2.81 | 35.14 | 2.00 | 0.56 | Upgrade |
EPS (Diluted) | 4.27 | 3.78 | 2.77 | 34.30 | 2.00 | 0.56 | Upgrade |
EPS Growth | 3.64% | 36.73% | -91.93% | 1615.80% | 257.03% | 273.27% | Upgrade |
Free Cash Flow | -11.34 | 912.83 | 1,557 | 18,010 | 222.67 | 407.85 | Upgrade |
Free Cash Flow Per Share | -0.03 | 2.07 | 3.44 | 38.53 | 0.49 | 0.94 | Upgrade |
Dividend Per Share | 0.200 | 0.200 | 0.300 | 2.500 | 0.700 | 0.060 | Upgrade |
Dividend Growth | -33.33% | -33.33% | -88.00% | 257.14% | 1066.67% | - | Upgrade |
Gross Margin | 64.16% | 69.72% | 60.54% | 78.99% | 63.09% | 54.86% | Upgrade |
Operating Margin | -15.00% | 26.12% | 23.29% | 70.30% | 38.35% | 20.69% | Upgrade |
Profit Margin | 120.37% | 64.38% | 38.74% | 60.92% | 37.91% | 12.07% | Upgrade |
Free Cash Flow Margin | -0.72% | 35.22% | 48.20% | 68.44% | 9.29% | 20.31% | Upgrade |
EBITDA | -236.17 | 709.44 | 829.08 | 18,574 | 985.28 | 478.25 | Upgrade |
EBITDA Margin | -15.05% | 27.37% | 25.66% | 70.58% | 41.10% | 23.81% | Upgrade |
D&A For EBITDA | -0.79 | 32.3 | 76.42 | 74.18 | 65.97 | 62.78 | Upgrade |
EBIT | -235.38 | 677.15 | 752.66 | 18,500 | 919.31 | 415.47 | Upgrade |
EBIT Margin | -15.00% | 26.12% | 23.29% | 70.30% | 38.35% | 20.69% | Upgrade |
Effective Tax Rate | 1.69% | 14.56% | 14.62% | 9.71% | 6.53% | 1.22% | Upgrade |
Revenue as Reported | 1,569 | 2,592 | 3,231 | 26,315 | 2,397 | 2,008 | Upgrade |
Advertising Expenses | - | 108.82 | 82.77 | 70.38 | 51.22 | 84.16 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.